IVF Clinical Trials 2023

What Are IVF Clinical Trials?

In-vitro fertilization is a complex series of procedures used to help with fertility or prevent genetic problems and assist with the conception of a child.

Why Is IVF Being Studied Through Clinical Trials?

With over a million babies born through IVF in the United States alone, In vitro fertilization is becoming an increasingly popular method for many parents. The average number of treatments needed for a woman under 30 is three. Further research aims to find more successful methods and procedures for in vitro fertilization therapies.

Several clinical trials are available for all women who are undergoing or want to undergo IVF treatment, including those for drugs that may induce ovulation.

What Are The Types of Treatments Available For IVF?

In vitro fertilization is a series of complicated medical procedures. It involves monitoring a woman's menstrual cycle to pinpoint ovulation and removing viable ovum. The ovum is combined with sperm in vitro. The viable embryos are then transplanted into the woman's uterus in the hopes of the embryo attaching and resulting in pregnancy.

What Are Some Recent Breakthrough Clinical Trials For IVF?

With IVF becoming an increasingly popular fertility treatment, researchers have made several important discoveries through clinical trials that may help future couples conceive. These discoveries include:

2009: Fast Track IVF Treatment – In a significant clinical trial by researchers in New England, research has shown that a fast-tracked or accelerated IVF approach proved more successful than standard treatments. The approach involved pre-treatment subcutaneous drugs before treatment, resulting in more successful births and more pregnancies after fewer treatments.

2018: Embryo Transfers – A New England study of 2157 women undergoing IVF treatment revealed little difference in results between women who received fresh embryos and frozen ones. However, it was found that using frozen embryos resulted in fewer cases of OHSS or ovarian hyperstimulation syndrome, which comes from a change in hormones during treatment.